SCHEMBL25944864

SCHEMBL25944864

c1ccc(-c2ccc(-c3cccc(-c4nc(-c5ccc6c(c5)sc5ccccc56)nc(-c5cccc6c5oc5ccccc56)n4)c3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.42
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
PRKDC P78527 2/20 0.35
GGPS1 O95749 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
F9 P00740 1/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
PIM3 Q86V86 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PLA2G10 O15496 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26080462 1.00 ALOX5 (0.42) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL25950676 0.99 ALOX5 (0.41) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL25645976 0.99 ALOX5 (0.41) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL26080467 0.97 ALOX5 (0.42) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL25852001 0.97 ALOX5 (0.44) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL26080576 0.97 ALOX5 (0.43) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL25050187 0.96 ALOX5 (0.42) ALOX5PRKDCGGPS1PTGES2F9
SCHEMBL26711154 0.96 ALOX5 (0.43) ALOX5PLA2G2APLA2G4APRKDCGGPS1
SCHEMBL21707323 0.96 ALOX5 (0.43) ALOX5PRKDCGGPS1PTGES2F9
SCHEMBL25050186 0.95 ALOX5 (0.40) ALOX5PLA2G2APLA2G4APRKDCGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4212526-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALOX5 579/4885PLA2G2A 3794/4885PLA2G4A 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.